A nonsignificant trend toward a reduced rate of late-stage ISR (achieved via inhibition of in-stent thrombosis rather than via reduction of neointimal hyperplasia) in the EPC capture stent group was also noted.
← all excerpts
Prevention of in-stent restenosis with endothelial progenitor cell (EPC) capture stent placement combined with regional EPC transplantation: An atherosclerotic rabbit model.
1
—
—